10/06/2026
🚨Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS that cuts treatment time by up to 75%.
Stereotactic body radiotherapy (SBRT) delivers higher radiation doses in fewer sessions, reducing side effects and the risk of tumour growth or spread.
Researchers from the ICR and The Royal Marsden NHS led the PACE-B trial that showed that these 5 high doses of radiation, given over one to two weeks, are just as effective as the standard radiotherapy – more moderate doses given over around 20 sessions.
The treatment will now be available on the NHS for men with low or intermediate risk prostate cancer. Trials are underway to test the treatment for men with high-risk disease.